CN110547331A - Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof - Google Patents
Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof Download PDFInfo
- Publication number
- CN110547331A CN110547331A CN201810539226.7A CN201810539226A CN110547331A CN 110547331 A CN110547331 A CN 110547331A CN 201810539226 A CN201810539226 A CN 201810539226A CN 110547331 A CN110547331 A CN 110547331A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- autism
- reducing
- mental retardation
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 41
- 206010003805 Autism Diseases 0.000 title claims abstract description 32
- 208000020706 Autistic disease Diseases 0.000 title claims abstract description 32
- 238000011161 development Methods 0.000 title claims abstract description 22
- 230000001737 promoting effect Effects 0.000 title claims abstract description 22
- 208000036626 Mental retardation Diseases 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 31
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 23
- 229940088594 vitamin Drugs 0.000 claims abstract description 22
- 229930003231 vitamin Natural products 0.000 claims abstract description 22
- 235000013343 vitamin Nutrition 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 19
- 239000011707 mineral Substances 0.000 claims abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 18
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 17
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 17
- 239000011710 vitamin D Substances 0.000 claims abstract description 17
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 17
- 229940046008 vitamin d Drugs 0.000 claims abstract description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011575 calcium Substances 0.000 claims abstract description 15
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 229910052742 iron Inorganic materials 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 39
- 238000002156 mixing Methods 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 18
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 18
- 229940045997 vitamin a Drugs 0.000 claims description 18
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- 239000005913 Maltodextrin Substances 0.000 claims description 12
- 229920002774 Maltodextrin Polymers 0.000 claims description 12
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 12
- 229930003270 Vitamin B Natural products 0.000 claims description 12
- 229930003448 Vitamin K Natural products 0.000 claims description 12
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 229940035034 maltodextrin Drugs 0.000 claims description 12
- 238000004806 packaging method and process Methods 0.000 claims description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 12
- 235000019156 vitamin B Nutrition 0.000 claims description 12
- 239000011720 vitamin B Substances 0.000 claims description 12
- 235000019168 vitamin K Nutrition 0.000 claims description 12
- 239000011712 vitamin K Substances 0.000 claims description 12
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 12
- 229940046010 vitamin k Drugs 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 10
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 6
- 102000014171 Milk Proteins Human genes 0.000 claims description 6
- 108010011756 Milk Proteins Proteins 0.000 claims description 6
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims description 6
- 229930003537 Vitamin B3 Natural products 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 6
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 235000013734 beta-carotene Nutrition 0.000 claims description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 6
- 239000011648 beta-carotene Substances 0.000 claims description 6
- 229960002747 betacarotene Drugs 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 229960001231 choline Drugs 0.000 claims description 6
- 229910052804 chromium Inorganic materials 0.000 claims description 6
- 239000011651 chromium Substances 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- 229960004488 linolenic acid Drugs 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 6
- 235000021239 milk protein Nutrition 0.000 claims description 6
- 229910052750 molybdenum Inorganic materials 0.000 claims description 6
- 239000011733 molybdenum Substances 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical group C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 6
- 235000019175 phylloquinone Nutrition 0.000 claims description 6
- 239000011772 phylloquinone Substances 0.000 claims description 6
- 229960001898 phytomenadione Drugs 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 6
- 229940108325 retinyl palmitate Drugs 0.000 claims description 6
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 6
- 239000011769 retinyl palmitate Substances 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 235000019160 vitamin B3 Nutrition 0.000 claims description 6
- 239000011708 vitamin B3 Substances 0.000 claims description 6
- 235000019158 vitamin B6 Nutrition 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 229940011671 vitamin b6 Drugs 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000019871 vegetable fat Nutrition 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- 230000036630 mental development Effects 0.000 claims 2
- 235000019155 vitamin A Nutrition 0.000 claims 2
- 239000011719 vitamin A Substances 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000018109 developmental process Effects 0.000 description 14
- 210000004556 brain Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008450 motivation Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 208000029560 autism spectrum disease Diseases 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000005305 organ development Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 208000029726 Neurodevelopmental disease Diseases 0.000 description 1
- 208000025890 Social Communication disease Diseases 0.000 description 1
- 206010042008 Stereotypy Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000010004 neural pathway Effects 0.000 description 1
- 210000000118 neural pathway Anatomy 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RMDJVOZETBHEAR-LQYWTLTGSA-N vitamin D5 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C RMDJVOZETBHEAR-LQYWTLTGSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention aims to disclose a formula powder for promoting the intelligence development of infants and reducing the morbidity of autism and mental retardation and a preparation method thereof, wherein the formula powder comprises the following components in percentage by mass: 30-55% of saccharides, 5-24% of proteins, 0-0.13% of vitamins, 4.717-9% of minerals and the like; wherein, vitamin D is 0-20IU/100ml, ferrum is 0-0.3mg/100ml, calcium is 30-50mg/100 ml; compared with the prior art, the invention has the advantages that the proportion of the nutrient components in the components, particularly iron, calcium and vitamin D, is reduced to promote the organism to release demand signals, improve and even prevent the autism, is suitable for the children suffering from the autism, and realizes the purpose of the invention.
Description
Technical Field
The invention relates to formula powder and a preparation method thereof, in particular to formula powder for promoting the intelligence development of infants and reducing the morbidity of autism, hyperactivity and mental retardation and a preparation method thereof.
Background
Autism Spectrum Disorder (ASD), abbreviated as autism, is synonymous with autism and is a group of neurodevelopmental disorders characterized mainly by social communication disorders, narrow interests or ranges of activities, and repetitive stereotypical behaviors, and the incidence of autism is increasing.
previously, researchers have conducted studies of the effects of malnutrition on intelligence in developing countries, where it was thought that childhood malnutrition affects intelligence and even work capacity after adulthood. With these studies, it cannot be deduced that the nutrition is better and the children are smarter. Unfortunately, most people engaged in intelligence and behavior research, and those engaged in children's nutrition research, have received strong implications from such research. If one suspects that autism is nutritionally related before, that must be taken into account what nutritional deficiency results in autism. Until recently, some studies of the positive significance of hunger on brain development gave us different perspectives.
The perfect nutritional status in early childhood (0-2 years) affects the development of positive emotions and motivations in children, especially the development of curiosity, leading to a series of social disturbances and repetitive stereotypy.
the brain has complete dominance on all organ tissues throughout the body, including organ development, organ functional strength and gene expression, which are all controlled by the brain. The brain must be able to sense the needs of the body organs whose afferent nerves carry these signals in order to achieve a full innervation of the body.
Autistic children are in a perfect nutritional state during the critical phase of early (0-2 years) positive motivation and positive mood formation, and the brain lacks the demand signals (level 2) that require behavioral resolution, which affects the maturation of the neural pathways that acquire motivation, as well as the generation of positive emotions. This may also explain why parents with autistic children often do not feel that a child has a need.
The critical stage of curious development in humans is 0-2 years of age. There must be enough demand signals from the body to create curiosity. The demand signal has two sources, one is nutrient deficiency and the other is a defect in the gene itself or a mismatch in the gene. The creation and maturation of curiosity can be ensured as long as one of them is present.
genes are randomly collocated, which makes most of us imperfect. The digestive ability, the heart function and the kidney function can ensure that certain organs of the body cannot be fully developed if the organs are slightly defective or mismatched, and the brain can continuously receive a demand signal, thereby promoting curiosity generation and maturity. Therefore, most people, especially children with serious defects, do not develop autism even if they are given perfect nutrition at an early stage. All genetic defects do not have a good appearance, and the better children grow, the more perfect the representative gene is. Such children, whose curious maturity depends only on a deficiency of early nutrition.
this protective setting is a very low iron content in human milk. The iron in the liver of breast-fed infants is gradually depleted in about 6 months, and organ development is affected by iron deficiency to signal demand. The infant brain has no experience addressing these demand signals, which translates into curiosity. Infants begin to curious about the novelty and often struggle around because they stop eating milk with a new sound. While iron fortified formula fed infants perform significantly less than the mother and baby.
Therefore, there is a need for a formula powder for promoting the intelligence development of infants and reducing the onset of autism and mental retardation and a preparation method thereof, so as to solve the existing problems.
Disclosure of Invention
the invention aims to provide formula powder for promoting intelligence development of infants and reducing the incidence of autism and mental retardation and a preparation method thereof, aiming at the defects of the prior art, the nutrition content, especially iron, in the formula powder is reduced, so that a demand signal is promoted to be released by an organism, and the autism is improved and even prevented.
In order to achieve the above object, the technical problem solved by the present invention can be achieved by adopting the following technical solutions:
On one hand, the invention discloses formula powder for promoting intelligence development of infants and reducing the incidence of autism and mental retardation, which is characterized by comprising the following components in percentage by mass:
30-55% of saccharides, 5-24% of proteins, 0-0.13% of vitamins, 4.717-9% of minerals and the like; wherein, vitamin D is 0-20IU/100ml, ferrum is 0-0.3mg/100ml, and calcium is 30-50mg/100 ml.
In one embodiment of the present invention, the vegetable fat powder includes, but is not limited to, any one of or a mixture of at least two of isolated milk protein, casein powder, linoleic acid or alpha linolenic acid.
in one embodiment of the invention, the saccharide includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose or fructose.
Further, the formula powder comprises 0-16% of maltodextrin (by mass percent).
In one embodiment of the invention, the vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
Further, preferably, the vitamin a comprises vitamin a palmitate and/or vitamin a beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
in one embodiment of the present invention, the minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
On the other hand, the invention discloses a formula powder for promoting the intelligence development of infants and reducing the incidence of autism and mental retardation and a preparation method thereof, which is characterized by comprising the following steps:
(1) Preparing materials: weighing the components according to a predetermined proportion;
(2) Mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) And (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) Packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
compared with the prior art, the formula powder for promoting the intelligence development of infants and reducing the morbidity of autism and mental retardation and the preparation method thereof have the advantages that the proportion of nutrient components in the components, particularly iron, calcium and vitamin D, is reduced to promote the organism to release demand signals, improve and even prevent the autism, are suitable for the patients with the autism, and achieve the purpose of the invention.
Detailed Description
In order to make the technical means, the creation features, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
Example 1
the formula powder for promoting the intelligence development of infants and reducing the incidence of autism and mental retardation comprises the following components in percentage by mass:
55% of saccharides, 24% of proteins, 0.13% of vitamins, 9% of minerals and the like; wherein, vitamin D20 IU/100ml, ferrum 0.3mg/100ml and calcium 50mg/100 ml.
The preparation method comprises the following steps:
(1) preparing materials: weighing the components according to a predetermined proportion;
(2) mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) And (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) Packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
Wherein, the plant fat powder comprises but is not limited to any one or the mixture of at least two of separated milk protein, cool protein powder, linoleic acid or alpha linolenic acid.
The saccharide includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose or fructose.
The formula powder comprises 16% of maltodextrin (by mass percent).
The vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
Preferably, the vitamin a comprises vitamin a palmitate and/or vitamin a of beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
the minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
Example 2
The formula powder for promoting the intelligence development of infants and reducing the incidence of autism and mental retardation comprises the following components in percentage by mass:
42.5% of saccharides, 15% of proteins, 0.06% of vitamins, 6.717% of minerals and the like; wherein, vitamin D10 IU/100ml, ferrum 0.15mg/100ml and calcium 40mg/100 ml.
The preparation method comprises the following steps:
(1) Preparing materials: weighing the components according to a predetermined proportion;
(2) mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) And (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) Packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
Wherein, the plant fat powder comprises but is not limited to any one or the mixture of at least two of separated milk protein, cool protein powder, linoleic acid or alpha linolenic acid.
the saccharide includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose or fructose.
The formula powder comprises 8% of maltodextrin (by mass percent).
The vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
Preferably, the vitamin a comprises vitamin a palmitate and/or vitamin a of beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
The minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
example 3
The formula powder for promoting the intelligence development of infants and reducing the incidence of autism and mental retardation comprises the following components in percentage by mass:
50% of saccharides, 19% of proteins, 0.11% of vitamins, 7.93% of minerals and the like; wherein, vitamin D15 IU/100ml, ferrum 0.225mg/100ml and calcium 45mg/100 ml.
The preparation method comprises the following steps:
(1) Preparing materials: weighing the components according to a predetermined proportion;
(2) mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) And (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) Packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
wherein, the plant fat powder comprises but is not limited to any one or the mixture of at least two of separated milk protein, cool protein powder, linoleic acid or alpha linolenic acid.
The saccharide includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose or fructose.
The formula powder comprises 12% of maltodextrin (by mass).
The vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
Preferably, the vitamin a comprises vitamin a palmitate and/or vitamin a of beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
The minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
example 4
The formula powder for promoting the intelligence development of infants and reducing the incidence of autism and mental retardation comprises the following components in percentage by mass:
36.25% of saccharides, 9.75% of proteins, 0.33% of vitamins, 1.07% of minerals and the like; wherein, vitamin D5 IU/100ml, ferrum 0.075mg/100ml and calcium 35mg/100 ml.
The preparation method comprises the following steps:
(1) Preparing materials: weighing the components according to a predetermined proportion;
(2) Mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) and (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
wherein, the plant fat powder comprises but is not limited to any one or the mixture of at least two of separated milk protein, cool protein powder, linoleic acid or alpha linolenic acid.
The saccharide includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose or fructose.
The formula powder comprises 4% of maltodextrin (by mass percent).
The vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
Preferably, the vitamin a comprises vitamin a palmitate and/or vitamin a of beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
the minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are merely illustrative of the principles of the invention, but that various changes and modifications may be made without departing from the spirit and scope of the invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.
Claims (8)
1. the formula powder for promoting the intelligence development of infants and reducing the morbidity of autism and mental retardation is characterized by comprising the following components in percentage by mass:
30-55% of saccharides, 5-24% of proteins, 0-0.13% of vitamins, 4.717-9% of minerals and the like; wherein, vitamin D is 0-20IU/100ml, ferrum is 0-0.3mg/100ml, and calcium is 30-50mg/100 ml.
2. The formula powder for promoting intelligence development of infants and young children and reducing the onset of autism and mental retardation as claimed in claim 1, wherein the vegetable fat powder comprises any one or a mixture of at least two of but not limited to isolated milk protein, casein powder, linoleic acid or alpha linolenic acid.
3. The powder formulation for promoting intelligence development and reducing the incidence of autism and mental retardation in an infant and child according to claim 1, wherein the sugar includes, but is not limited to, any one or a mixture of at least two of lactose, sucrose, maltodextrin, glucose, or fructose.
4. The formula powder for promoting intelligence development of infants and children and reducing onset of autism and mental retardation as claimed in claim 3, wherein the formula powder comprises 0-16% of maltodextrin (mass percent).
5. The powder formulation for promoting intelligence development and reducing the incidence of autism and mental retardation in an infant and pre-school child according to claim 1, wherein the vitamins include, but are not limited to, any one or a mixture of at least two of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, biotin, pantothenic acid, and choline.
6. Formula for use in promoting the mental development of infants and young children and reducing the onset of autism and mental retardation according to claim 5, characterized in that, preferably, the vitamin A comprises vitamin A palmitate and/or vitamin A beta-carotene; the vitamin B comprises any one or a mixture of at least two of vitamin B1, vitamin B2, vitamin B3, vitamin B6 or vitamin B12; the vitamin D is vitamin D3; the vitamin K is vitamin K1.
7. The powder formulation for promoting mental development and reducing the incidence of autism and mental retardation in an infant or young child according to claim 1, wherein the minerals include, but are not limited to, any one or a mixture of at least two of sodium, potassium, chloride, calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, and molybdenum.
8. a formula powder for promoting the intelligence development of infants and reducing the morbidity of autism and mental retardation and a preparation method thereof are characterized by comprising the following steps:
(1) Preparing materials: weighing the components according to a predetermined proportion;
(2) Mixing materials: mixing the mineral substances and the vitamins weighed according to a preset proportion, sequentially adding the saccharides and the other components, placing the mixture in a three-dimensional dry mixer, and mixing the materials for 20-30 minutes;
(3) And (3) sterilization: mixing, placing in a pasteurizer, maintaining at 80-100 deg.C for 5-10 min, and rapidly cooling to 35-45 deg.C;
(4) packaging: and packaging by filling nitrogen or carbon dioxide in vacuum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810539226.7A CN110547331A (en) | 2018-05-30 | 2018-05-30 | Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810539226.7A CN110547331A (en) | 2018-05-30 | 2018-05-30 | Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110547331A true CN110547331A (en) | 2019-12-10 |
Family
ID=68734711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810539226.7A Pending CN110547331A (en) | 2018-05-30 | 2018-05-30 | Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110547331A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038041A (en) * | 2010-11-17 | 2011-05-04 | 许德建 | Mineral substance formula milk powder for infants |
CN105831253A (en) * | 2016-03-23 | 2016-08-10 | 无锡超科食品科技有限公司 | Lactose-free infant formula milk powder and preparation method thereof |
CN106417618A (en) * | 2016-08-31 | 2017-02-22 | 广西梧州市港圣堂保健食品有限公司 | Selenium-enriched foods suitable for preschool children and preparation method thereof |
-
2018
- 2018-05-30 CN CN201810539226.7A patent/CN110547331A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038041A (en) * | 2010-11-17 | 2011-05-04 | 许德建 | Mineral substance formula milk powder for infants |
CN105831253A (en) * | 2016-03-23 | 2016-08-10 | 无锡超科食品科技有限公司 | Lactose-free infant formula milk powder and preparation method thereof |
CN106417618A (en) * | 2016-08-31 | 2017-02-22 | 广西梧州市港圣堂保健食品有限公司 | Selenium-enriched foods suitable for preschool children and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
申艳芝: "《吃出超级大脑 大脑营养真相》", 31 January 2017, 北京联合出版公司 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hernell et al. | Clinical benefits of milk fat globule membranes for infants and children | |
CN104411184B (en) | Alimentation composition | |
Camara-Martos et al. | Influence of dietary factors on calcium bioavailability: a brief review | |
ES2764089T3 (en) | Nutritional composition that has lipophilic compounds with improved solubility and bioavailability | |
Komrower et al. | Dietary treatment of homocystinuria. | |
JP2012530067A (en) | Glycomacropeptide medical food for nutritional management of phenylketonuria and other metabolic disorders | |
US20100119617A1 (en) | Multi-nutrient milk fortifier | |
CN106605709B (en) | Liquid milk suitable for children of 3-6 years old and preparation method thereof | |
RU2508409C2 (en) | Sugar-containing product manufacture method | |
CN106819125B (en) | Dairy product and method for producing the same | |
CN106937677B (en) | Total-nutrient formula dairy product added with coconut particles and preparation method thereof | |
SE537951C2 (en) | Prophylactic use of infant formula for otitis | |
CN107048137A (en) | It is a kind of suitable for low-phosphorus whey albumen powder of Patients with Chronic Renal Disease and preparation method thereof | |
CN111345358A (en) | Child formula goat milk powder rich in lactophospholipid and preparation method thereof | |
EP1869985B1 (en) | Use of a milk protein in a composition comprising iron and vitamin c to avoid an astringent taste of iron or the formation of precipitates, wherein the milk protein is skim milk or whey protein isolate | |
de la Fuente et al. | Milk and dairy products | |
Michael Hambidge | The importance of trace elements in infant nutrition | |
JP2007022989A (en) | Anti-fatigue agent | |
CN106615138A (en) | Breast milk nutritious supplementary agent and preparation method thereof | |
CN110547331A (en) | Formula powder for promoting intelligence development of infants and reducing onset of autism and mental retardation and preparation method thereof | |
Daly et al. | Protein substitutes in PKU; their historical evolution. Nutrients. 2021; 13: 484 | |
RU2827875C1 (en) | Milk drink enriched with colloidal chelate forms of essential trace elements of zinc, manganese, iron, copper and cobalt, and method for its production | |
WO2006024241A1 (en) | Preparation comprising ionic iron and haem iron and variants thereof for the prophylaxis and treatment of iron deficiency | |
KR900008077B1 (en) | High fat low carbohydrate eternal nutritional formula | |
EP4057841B1 (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191210 |
|
WD01 | Invention patent application deemed withdrawn after publication |